Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT for Moderate to Severe CDI
NCT02570477Unknown
- Sponsor
- The Chinese University of Hong Kong
- Start
- Jan 2015
- Primary completion
- Jan 2018
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Randomised, open-label trial of fecal microbiome transplant in Clostridioides difficile infection (CDI) (2 arms), sponsored by The Chinese University of Hong Kong. Primary endpoint: Number of participants cured without relapse at 10 weeks. Status: unknown.
02
Drugs
fecal microbiome transplant
03
Conditions
Clostridioides difficile infection (CDI)
Beyond the preview
Go deeper on NCT02570477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02570477.